Cargando…
Optimal Duration of Systemic Corticosteroids in Coronavirus Disease 2019 Treatment: A Systematic Review and Meta-analysis
BACKGROUND: Corticosteroids confer a survival benefit in individuals hospitalized with coronavirus disease 2019 (COVID-19) who require oxygen. This meta-analysis seeks to determine the duration of corticosteroids needed to optimize this mortality benefit. METHODS: Electronic databases were searched...
Autores principales: | Ssentongo, Paddy, Yu, Nyein, Voleti, Navya, Reddy, Surya, Ingram, David, Chinchilli, Vernon M, Paules, Catharine I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026544/ https://www.ncbi.nlm.nih.gov/pubmed/36949880 http://dx.doi.org/10.1093/ofid/ofad105 |
Ejemplares similares
-
1138. Optimal Duration of Systemic Corticosteroids Use in COVID-19 Treatment: A Meta-analysis
por: Yu, Nyein, et al.
Publicado: (2022) -
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
por: Ssentongo, Paddy, et al.
Publicado: (2022) -
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis
por: Voleti, Navya, et al.
Publicado: (2022) -
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients
por: Shah, Meera, et al.
Publicado: (2023) -
1339. Effects of Tixagevimab-Cilgavimab in Clinical Practice is Consistent with Preliminary Neutralization Studies
por: Dluzynski, Daniela, et al.
Publicado: (2023)